Skip to main content

Security report for terumo-ps.com

Terumo Europe NV · Healthcare · Belgium

Medium risk. 3 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

Terumo Pharmaceutical Solutions is a division of Terumo Corporation, a global healthcare technology leader founded in 1921 and headquartered in Tokyo, Japan. The division specializes in pharmaceutical and medical device manufacturing, offering injection, infusion, and primary packaging solutions alongside contract development and manufacturing services (CDMO). The company targets pharmaceutical professionals worldwide, emphasizing patient comfort and product quality. The website reflects a mature, professional business with a strong global presence and comprehensive product portfolio. Technically, the site is built on Microsoft SharePoint, leveraging modern JavaScript libraries and frameworks such as jQuery and Bootstrap, with integrated Google Analytics and Tag Manager for user tracking. The site is mobile optimized and SEO friendly, though accessibility features are basic. Security posture is good with HTTPS enforced and cookie consent implemented, but lacks explicit security headers and incident response information. WHOIS data is incomplete, indicating possible privacy protection, which slightly reduces domain transparency but does not detract from the overall legitimacy given the strong brand presence and external references. Overall, the website is professional, trustworthy, and well-maintained, serving a specialized B2B healthcare market.

Scanned

NIS2 and GDPR posture

GDPR outside view
85/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching terumo-ps.com

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
55
Email security
70
DNS health
70
Network security
100
GDPR outside view
85
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Terumo Pharmaceutical Solutions operates in the healthcare sector, focusing on pharmaceutical device manufacturing and services. Their business model is B2B, serving pharmaceutical and medical device manufacturers globally. The company benefits from the strong brand and resources of its parent, Terumo Corporation. Their competitive advantage lies in product quality, innovation, and comprehensive service offerings including CDMO. The website indicates active participation in industry events and a broad product portfolio targeting pharmaceutical professionals. The presence of multiple related domains and social media channels supports a robust partnership ecosystem. Growth indicators include ongoing product development and global market reach. Strategic observations suggest a focus on patient comfort and regulatory compliance as key differentiators.

Security posture

The website demonstrates a good security maturity level with HTTPS enforced and cookie consent mechanisms in place, supporting GDPR compliance. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, the absence of security headers such as Content Security Policy (CSP), X-Frame-Options, and HSTS reduces the overall security posture. There is no visible security policy or incident response contact information, which is a gap in transparency and readiness. The use of third-party scripts like Google Analytics and jQuery requires ongoing vulnerability management. Overall, the security posture is solid but could be improved by implementing additional HTTP security headers and publishing clear security policies.

Recommendations

  1. Implement comprehensive HTTP security headers including CSP, HSTS, X-Frame-Options, and X-XSS-Protection to enhance protection against common web attacks.
  2. Publish a dedicated security policy and incident response contact information to improve transparency and readiness.
  3. Regularly audit and update third-party libraries and scripts to mitigate vulnerabilities.
  4. Enhance website accessibility features to meet higher standards and improve user experience for all users.
  5. Consider publishing a security.txt file or vulnerability disclosure policy to facilitate responsible reporting of security issues.

Contact details published on the site

Addresses
Legal name
Terumo Europe NV
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Terumo Europe NV
Description
Terumo Medical Care Solutions- Pharmaceutical is a division of Terumo Corporation (TSE:4543) based in Tokyo, Japan. A global healthcare technology leader since 1921, Terumo employs over 30,000 associates across key international markets. The company delivers a full portfolio of medical and parenteral delivery solutions to more than 160 countries and regions worldwide.
Key services
injection devices, infusion sets, primary packaging, CDMO services, design and development services
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Bootstrap, Slick Carousel, Google Analytics, Google Tag Manager, Microsoft SharePoint
Frameworks
SharePoint Portal Framework
Platforms
Microsoft SharePoint
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • cookie consent banner
  • no exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and professional design
  2. No WAF or blocking detected
  3. Uses Microsoft SharePoint CMS platform
  4. Strong focus on pharmaceutical and healthcare industry
  5. Includes cookie consent and privacy policy compliant with GDPR
  6. No explicit security.txt or incident response info found
  7. WHOIS data is missing or unavailable, reducing domain transparency
  8. Multiple external trusted domains linked
  9. Google Analytics and Tag Manager used for tracking
  10. No adult or questionable content detected
Technical notes

Notes

The website is built on Microsoft SharePoint, utilizing jQuery, Bootstrap, and Slick Carousel for UI components and interactivity. Google Analytics and Google Tag Manager are integrated for analytics and user tracking. The site is mobile responsive with good SEO practices including canonical links and structured data in JSON-LD format. Performance is moderate, typical for SharePoint-based sites. Accessibility is basic with some skip links and ARIA roles but could be improved. The technical stack is modern but relies on legacy jQuery versions which may pose security risks if not updated. The site uses multiple CSS and JS libraries hosted locally and externally. Overall, the technical infrastructure supports a professional and functional website but has room for modernization and security hardening.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with terumo-ps.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review terumo-ps.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.